Ralstonia pickettii:在摩洛哥的一个儿科重症监护病房里,有两例细菌病例
Ibtissam Nabih1, Youssef Idbaha1, Ouissal Aissaoui1
1Anesthesia and Critical Care, Ibn Rochd University Hospital, Hassan II University of Casablanca, Casablanca, MAR.
Cureus
|May 14, 2025
概括
拉尔斯托尼亚皮克特蒂 (Ralstonia pickettii) 的血液感染对重症监护室的脆弱患者构成重大威胁. 加强感染控制和向治疗对于打击这种新兴的机会性病原体至关重要.
科学领域:
- 医学微生物学 医学微生物学
- 传染性疾病 传染性疾病
- 医院流行病学 医院流行病学
背景情况:
- 拉尔斯托尼亚皮克蒂 (Ralstonia pickettii) 是一种新兴的机会性病原体,会引起医院感染,特别是在免疫力低下的人群中.
- 它在水环境中的持久性和殖民医疗设备的能力促进了医院获得的疫情.
- 管理R. pickettii感染是具有挑战性的,因为其内在的耐药性和潜在的多药耐药性.
研究的目的:
- 在儿科重症监护病房报告Ralstonia pickettii血流感染的两例病例.
- 突出临床挑战和结局与R. pickettii感染的关键病症儿童.
- 强调需要改善对这种新兴病原体的监测和感染控制策略.
主要方法:
- 关于两名患有R. pickettii血流感染的儿科患者的病例报告.
- 对临床数据的审查,包括患者人口统计,临床表现,治疗方案和结果.
- 分离病原体的微生物学识别和敏感性测试.
主要成果:
- 在摩洛哥的儿科重症监护病房中出现了两例R. pickettii血流感染的病例.
- 两位患者,即重症婴儿和儿童,尽管进行了积极的抗菌药物治疗,但经历了严重的结果,包括死亡.
- 第二个病例涉及其他多种耐药生物体的多微生物感染.
结论:
- 拉尔斯托尼亚皮克蒂作为医院病原体构成越来越大的威胁,特别是在儿科重症监护机构.
- 有效的管理需要强有力的感染控制措施,增强的诊断能力和适应性的治疗策略.
- 持续的医院监测和严格遵守无菌技术对于防止R. pickettii传播至关重要.
更多相关视频
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
14.5K
03:22Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
340
相关概念视频
01:30Pneumonia III: Complications and Assessment
130
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
130
01:30Pneumonia I: Introduction
192
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
192
01:28Pneumonia IV: Management
271
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
271